Clinical Outcomes of Commercial CD19-Targeted CAR T-Cell Therapy in Patients With Secondary Central Nervous System Lymphoma

被引:0
|
作者
Ababneh, Hazim [1 ]
Frigault, Matthew [1 ]
Patel, Chirayu [1 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA USA
来源
关键词
ABCL; high-grade B-cell lymphoma; anti-CD19 CAR T-cell therapy; secondary CNS malignancy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ABCL-044
引用
收藏
页码:S355 / S355
页数:1
相关论文
共 50 条
  • [31] Effect of transplant status in CD19-targeted CAR T-cell therapy: a systematic review and meta-analysis
    Nagle, Kathleen
    Tafuto, Barbara
    Kim, Lisa Palladino
    Parrott, J. Scott
    MEDICAL ONCOLOGY, 2018, 35 (11)
  • [32] Reverse fate mapping of CD19-targeted CAR T cells in patients with large B-cell lymphoma
    Good, Zinaida
    Hamilton, Mark P.
    Spiegel, Jay Y.
    Kurra, Sreevidya
    Desai, Moksha
    Prabhu, Snehit
    Yang, Eric
    Ozawa, Michael G.
    Hanson, Paul J.
    Wu, Fang
    Frank, Matthew J.
    Baird, John H.
    Muffly, Lori
    Claire, Gursharan K.
    Craig, Juliana
    Kong, Katherine A.
    Wagh, Dhananjay
    Coller, John
    Plevritis, Sylvia K.
    Sahaf, Bita
    Miklos, David B.
    Mackall, Crystal L.
    CANCER RESEARCH, 2022, 82 (12)
  • [33] Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma
    Kuipers, Maria T.
    Spanjaart, Anne M.
    Bonifazi, Francesca
    diBlasi, Roberta
    Zinzani, Pier L.
    Thieblemont, Catherine
    Baudet, Mathilde
    Biemond, Bart J.
    Kok, Wouter E. M.
    Kersten, Marie J.
    LEUKEMIA & LYMPHOMA, 2024, 65 (03) : 399 - 402
  • [34] Effect of transplant status in CD19-targeted CAR T-cell therapy: a systematic review and meta-analysis
    Kathleen Nagle
    Barbara Tafuto
    Lisa Palladino Kim
    J. Scott Parrott
    Medical Oncology, 2018, 35
  • [35] CD19 or CD20 CAR T Cell Therapy Demonstrates Durable Antitumor Efficacy in Patients with Central Nervous System Lymphoma
    Liu, Rui
    Cheng, Qian
    Kang, Liqing
    Wang, Erhua
    Li, Ying
    Zhang, Jian
    Xiao, Han
    Zhang, Yi
    Chu, Ling
    Chen, Xin
    Zhang, Chang
    Tan, Jingwen
    Xu, Nan
    Li, Minghao
    Yu, Lei
    Li, Xin
    HUMAN GENE THERAPY, 2022, 33 (5-6) : 318 - 329
  • [36] Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells
    Kathryn Kline
    Tim Luetkens
    Rima Koka
    Michael E. Kallen
    Wengen Chen
    Haroon Ahmad
    Destiny Omili
    Thierry Iraguha
    Etse Gebru
    Xiaoxuan Fan
    Alexis Miller
    Nishanthini Dishanthan
    Jillian M. Baker
    Kenneth A. Dietze
    Kim G. Hankey
    Jean A. Yared
    Nancy M. Hardy
    Aaron P. Rapoport
    Saurabh Dahiya
    Djordje Atanackovic
    Cancer Immunology, Immunotherapy, 73
  • [37] Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells
    Kline, Kathryn
    Luetkens, Tim
    Koka, Rima
    Kallen, Michael E.
    Chen, Wengen
    Ahmad, Haroon
    Omili, Destiny
    Iraguha, Thierry
    Gebru, Etse
    Fan, Xiaoxuan
    Miller, Alexis
    Dishanthan, Nishanthini
    Baker, Jillian M.
    Dietze, Kenneth A.
    Hankey, Kim G.
    Yared, Jean A.
    Hardy, Nancy M.
    Rapoport, Aaron P.
    Dahiya, Saurabh
    Atanackovic, Djordje
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (03)
  • [38] Outcome correlates of approved CD19-targeted CAR T cells for large B cell lymphoma
    Bock, Tamara J.
    Colonne, Chanukya K.
    Fiorenza, Salvatore
    Turtle, Cameron J.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2025, : 241 - 261
  • [39] Evaluation of the clinicopathologic features of diffuse large B cell lymphoma after CD19-targeted CAR T-cell therapy emphasizing the potential diagnostic pitfalls
    Zhou, Jun
    Zhang, Wenjing
    Zhang, Yanping
    Zheng, Saifang
    Zhou, Luting
    Yang, Xiaoqun
    Wang, Chaofu
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (10): : 6751 - 6762
  • [40] Abnormal Coagulation Function in CD19-Targeted CAR-T Therapy
    Jiang, Huiwen
    Mei, Heng
    Dong, Jian
    Hu, Yu
    BLOOD, 2017, 130